ID   UBP20_HUMAN             Reviewed;         914 AA.
AC   Q9Y2K6; Q541F1; Q8IXQ1; Q96LG5; Q9UQN8; Q9UQP0;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   15-MAR-2017, entry version 160.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 20;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 20;
DE   AltName: Full=Ubiquitin thioesterase 20;
DE   AltName: Full=Ubiquitin-specific-processing protease 20;
DE   AltName: Full=VHL-interacting deubiquitinating enzyme 2;
DE            Short=hVDU2;
GN   Name=USP20; Synonyms=KIAA1003, LSFR3A, VDU2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, UBIQUITINATION, AND INTERACTION
RP   WITH VHL.
RX   PubMed=12056827; DOI=10.1016/S0006-291X(02)00534-X;
RA   Li Z., Wang D., Na X., Schoen S.R., Messing E.M., Wu G.;
RT   "Identification of a deubiquitinating enzyme subfamily as substrates
RT   of the von Hippel-Lindau tumor suppressor.";
RL   Biochem. Biophys. Res. Commun. 294:700-709(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 581-803 AND 839-914.
RX   PubMed=10369878; DOI=10.1093/hmg/8.7.1313;
RA   Gilley J., Fried M.;
RT   "Extensive gene order differences within regions of conserved synteny
RT   between the Fugu and human genomes: implications for chromosomal
RT   evolution and the cloning of disease genes.";
RL   Hum. Mol. Genet. 8:1313-1320(1999).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH DIO2.
RX   PubMed=12865408; DOI=10.1172/JCI18348;
RA   Curcio-Morelli C., Zavacki A.M., Christofollete M., Gereben B.,
RA   de Freitas B.C., Harney J.W., Li Z., Wu G., Bianco A.C.;
RT   "Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-
RT   Lindau protein-interacting deubiquitinating enzymes regulates thyroid
RT   hormone activation.";
RL   J. Clin. Invest. 112:189-196(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH HIF1A.
RX   PubMed=15776016; DOI=10.1038/sj.embor.7400377;
RA   Li Z., Wang D., Messing E.M., Wu G.;
RT   "VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and
RT   stabilizes HIF-1alpha.";
RL   EMBO Rep. 6:373-378(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-134, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-377 AND SER-413, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, INTERACTION WITH ADRB2, AND MUTAGENESIS OF CYS-154 AND
RP   HIS-643.
RX   PubMed=19424180; DOI=10.1038/emboj.2009.128;
RA   Berthouze M., Venkataramanan V., Li Y., Shenoy S.K.;
RT   "The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic
RT   receptor recycling and resensitization.";
RL   EMBO J. 28:1684-1696(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-134, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-132; SER-134;
RP   SER-305; THR-377; SER-408 AND SER-413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CCP110.
RX   PubMed=23486064; DOI=10.1038/nature11941;
RA   Li J., D'Angiolella V., Seeley E.S., Kim S., Kobayashi T., Fu W.,
RA   Campos E.I., Pagano M., Dynlacht B.D.;
RT   "USP33 regulates centrosome biogenesis via deubiquitination of the
RT   centriolar protein CP110.";
RL   Nature 495:255-259(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-134, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Deubiquitinating enzyme involved in beta-2 adrenergic
CC       receptor (ADRB2) recycling. Acts as a regulator of G-protein
CC       coupled receptor (GPCR) signaling by mediating the
CC       deubiquitination beta-2 adrenergic receptor (ADRB2). Plays a
CC       central role in ADRB2 recycling and resensitization after
CC       prolonged agonist stimulation by constitutively binding ADRB2,
CC       mediating deubiquitination of ADRB2 and inhibiting lysosomal
CC       trafficking of ADRB2. Upon dissociation, it is probably
CC       transferred to the translocated beta-arrestins, possibly leading
CC       to beta-arrestins deubiquitination and disengagement from ADRB2.
CC       This suggests the existence of a dynamic exchange between the
CC       ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating
CC       thyroid hormone regulation. Deubiquitinates HIF1A, leading to
CC       stabilize HIF1A and enhance HIF1A-mediated activity. Mediates
CC       deubiquitination of both 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitin chains. {ECO:0000269|PubMed:12056827,
CC       ECO:0000269|PubMed:12865408, ECO:0000269|PubMed:15776016,
CC       ECO:0000269|PubMed:19424180}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts with VHL, leading to its ubiquitination and
CC       subsequent degradation. Interacts with CCP110, DIO2 and HIF1A.
CC       {ECO:0000269|PubMed:12056827, ECO:0000269|PubMed:12865408,
CC       ECO:0000269|PubMed:15776016, ECO:0000269|PubMed:19424180,
CC       ECO:0000269|PubMed:23486064}.
CC   -!- INTERACTION:
CC       P13196:ALAS1; NbExp=3; IntAct=EBI-2511991, EBI-3905054;
CC       Q7L4P6:BEND5; NbExp=3; IntAct=EBI-2511991, EBI-724373;
CC       Q8N7W2-2:BEND7; NbExp=3; IntAct=EBI-2511991, EBI-10181188;
CC       Q8IYA8:CCDC36; NbExp=3; IntAct=EBI-2511991, EBI-8638439;
CC       Q969F0:FATE1; NbExp=3; IntAct=EBI-2511991, EBI-743099;
CC       P43364-2:MAGEA11; NbExp=3; IntAct=EBI-2511991, EBI-10178634;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-2511991, EBI-724076;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-2511991, EBI-742487;
CC       P36406:TRIM23; NbExp=3; IntAct=EBI-2511991, EBI-740098;
CC       Q53XM7:VAPB; NbExp=3; IntAct=EBI-2511991, EBI-10178947;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:23486064}. Note=According to PubMed:12865408,
CC       it localizes in the endoplasmic reticulum; however the relevance
CC       of such result is unclear.
CC   -!- DOMAIN: The UBP-type zinc finger binds 3 zinc ions. However, it
CC       does not bind ubiquitin, probably because the conserved Arg in
CC       position 55 is replaced by a Glu residue (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated via a VHL-dependent pathway for proteasomal
CC       degradation. {ECO:0000269|PubMed:12056827}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP20/USP33
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76847.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY074877; AAL79676.1; -; mRNA.
DR   EMBL; AB023220; BAA76847.2; ALT_INIT; mRNA.
DR   EMBL; AL158207; CAC88170.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87914.1; -; Genomic_DNA.
DR   EMBL; BC039593; AAH39593.1; -; mRNA.
DR   EMBL; Y17457; CAB44350.1; -; Genomic_DNA.
DR   EMBL; Y17459; CAB44352.1; -; Genomic_DNA.
DR   CCDS; CCDS43892.1; -.
DR   RefSeq; NP_001008563.2; NM_001008563.4.
DR   RefSeq; NP_001103773.2; NM_001110303.3.
DR   RefSeq; NP_006667.3; NM_006676.7.
DR   RefSeq; XP_005251722.1; XM_005251665.3.
DR   RefSeq; XP_011516463.1; XM_011518161.2.
DR   RefSeq; XP_011516464.1; XM_011518162.2.
DR   UniGene; Hs.5452; -.
DR   ProteinModelPortal; Q9Y2K6; -.
DR   BioGrid; 116077; 68.
DR   IntAct; Q9Y2K6; 50.
DR   MINT; MINT-4658328; -.
DR   STRING; 9606.ENSP00000313811; -.
DR   BindingDB; Q9Y2K6; -.
DR   ChEMBL; CHEMBL3232682; -.
DR   MEROPS; C19.025; -.
DR   iPTMnet; Q9Y2K6; -.
DR   PhosphoSitePlus; Q9Y2K6; -.
DR   DMDM; 116242837; -.
DR   EPD; Q9Y2K6; -.
DR   MaxQB; Q9Y2K6; -.
DR   PaxDb; Q9Y2K6; -.
DR   PeptideAtlas; Q9Y2K6; -.
DR   PRIDE; Q9Y2K6; -.
DR   Ensembl; ENST00000315480; ENSP00000313811; ENSG00000136878.
DR   Ensembl; ENST00000358355; ENSP00000351122; ENSG00000136878.
DR   Ensembl; ENST00000372429; ENSP00000361506; ENSG00000136878.
DR   GeneID; 10868; -.
DR   KEGG; hsa:10868; -.
DR   UCSC; uc004byr.4; human.
DR   CTD; 10868; -.
DR   DisGeNET; 10868; -.
DR   GeneCards; USP20; -.
DR   H-InvDB; HIX0008459; -.
DR   HGNC; HGNC:12619; USP20.
DR   HPA; HPA006287; -.
DR   HPA; HPA007008; -.
DR   MIM; 615143; gene.
DR   neXtProt; NX_Q9Y2K6; -.
DR   OpenTargets; ENSG00000136878; -.
DR   PharmGKB; PA37245; -.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00860000133682; -.
DR   HOGENOM; HOG000286031; -.
DR   HOVERGEN; HBG054196; -.
DR   InParanoid; Q9Y2K6; -.
DR   KO; K11848; -.
DR   OMA; WGQQRTN; -.
DR   OrthoDB; EOG091G02UV; -.
DR   PhylomeDB; Q9Y2K6; -.
DR   TreeFam; TF352179; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP20; human.
DR   GeneWiki; USP20; -.
DR   GenomeRNAi; 10868; -.
DR   PRO; PR:Q9Y2K6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136878; -.
DR   CleanEx; HS_USP20; -.
DR   Genevisible; Q9Y2K6; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IEA:InterPro.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.2230.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF06337; DUSP; 2.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00695; DUSP; 2.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF143791; SSF143791; 2.
DR   PROSITE; PS51283; DUSP; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Endocytosis; Hydrolase;
KW   Metal-binding; Phosphoprotein; Polymorphism; Protease;
KW   Reference proteome; Repeat; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    914       Ubiquitin carboxyl-terminal hydrolase 20.
FT                                /FTId=PRO_0000080647.
FT   DOMAIN      145    685       USP.
FT   DOMAIN      687    780       DUSP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      789    892       DUSP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   ZN_FING      28     92       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    154    154       Nucleophile.
FT   ACT_SITE    643    643       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     132    132       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     258    258       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C6M1}.
FT   MOD_RES     377    377       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     103    103       S -> Y (in dbSNP:rs36086252).
FT                                /FTId=VAR_051529.
FT   VARIANT     444    444       V -> I (in dbSNP:rs36055332).
FT                                /FTId=VAR_051530.
FT   MUTAGEN     154    154       C->S: Abolishes deubiquitinating
FT                                activity. Does not inhibit lysosomal
FT                                trafficking of ADRB2; when associated
FT                                with Q-643.
FT                                {ECO:0000269|PubMed:19424180}.
FT   MUTAGEN     643    643       H->Q: Abolishes deubiquitinating
FT                                activity. Does not inhibit lysosomal
FT                                trafficking of ADRB2; when associated
FT                                with S-154.
FT                                {ECO:0000269|PubMed:19424180}.
FT   CONFLICT    320    320       A -> V (in Ref. 1; AAL79676 and 2;
FT                                BAA76847). {ECO:0000305}.
FT   CONFLICT    359    359       Missing (in Ref. 1; AAL79676, 2;
FT                                BAA76847, 4; EAW87914 and 5; AAH39593).
FT                                {ECO:0000305}.
FT   CONFLICT    776    776       H -> Q (in Ref. 6; CAB44350).
FT                                {ECO:0000305}.
FT   CONFLICT    794    794       R -> M (in Ref. 6; CAB44350).
FT                                {ECO:0000305}.
SQ   SEQUENCE   914 AA;  102003 MW;  DC094570A396D20E CRC64;
     MGDSRDLCPH LDSIGEVTKE DLLLKSKGTC QSCGVTGPNL WACLQVACPY VGCGESFADH
     STIHAQAKKH NLTVNLTTFR LWCYACEKEV FLEQRLAAPL LGSSSKFSEQ DSPPPSHPLK
     AVPIAVADEG ESESEDDDLK PRGLTGMKNL GNSCYMNAAL QALSNCPPLT QFFLECGGLV
     RTDKKPALCK SYQKLVSEVW HKKRPSYVVP TSLSHGIKLV NPMFRGYAQQ DTQEFLRCLM
     DQLHEELKEP VVATVALTEA RDSDSSDTDE KREGDRSPSE DEFLSCDSSS DRGEGDGQGR
     GGGSSQAETE LLIPDEAGRA ISEKERMKDR KFSWGQQRTN SEQVDEDADV DTAMAALDDQ
     PAEAQPPSPR SSSPCRTPEP DNDAHLRSSS RPCSPVHHHE GHAKLSSSPP RASPVRMAPS
     YVLKKAQVLS AGSRRRKEQR YRSVISDIFD GSILSLVQCL TCDRVSTTVE TFQDLSLPIP
     GKEDLAKLHS AIYQNVPAKP GACGDSYAAQ GWLAFIVEYI RRFVVSCTPS WFWGPVVTLE
     DCLAAFFAAD ELKGDNMYSC ERCKKLRNGV KYCKVLRLPE ILCIHLKRFR HEVMYSFKIN
     SHVSFPLEGL DLRPFLAKEC TSQITTYDLL SVICHHGTAG SGHYIAYCQN VINGQWYEFD
     DQYVTEVHET VVQNAEGYVL FYRKSSEEAM RERQQVVSLA AMREPSLLRF YVSREWLNKF
     NTFAEPGPIT NQTFLCSHGG IPPHKYHYID DLVVILPQNV WEHLYNRFGG GPAVNHLYVC
     SICQVEIEAL AKRRRIEIDT FIKLNKAFQA EESPGVIYCI SMQWFREWEA FVKGKDNEPP
     GPIDNSRIAQ VKGSGHVQLK QGADYGQISE ETWTYLNSLY GGGPEIAIRQ SVAQPLGPEN
     LHGEQKIEAE TRAV
//
